Inventor · disambiguated record
Vinuta Kamat
Also filed as: KAMAT VINUTA
9 granted patents·0 citations·filing 2023–2024
75Inventor score
Top patents by PatentIndex Score
9 records- 0177US11964982B15-(3-substituted phenyl)-pyrimido[4,5-d]pyrimidine-2,4,7(1H,3H,8H)-trione derivatives as anticancer agentsUNIV KING FAISAL·Filed 2023·Granted Apr 23, 2024·0 cites·6 claims
- 0277US11884677B15-(substitutedphenyl)-7-imino-7,8-dihydropyrimido[4,5-d]pyrimidine-2,4(1H,3H)-dione analogues as anti-inflammatory agentsUNIV KING FAISAL·Filed 2023·Granted Jan 30, 2024·0 cites·14 claims
- 0375US12297204B25-(substitutedphenyl)-7-thioxo-7,8-dihydropyrimido[4,5-d]pyrimidine-2,4(1H,3H)-dione analogues as antibacterial agentsUNIV KING FAISAL·Filed 2024·Granted May 13, 2025·0 cites·8 claims
- 0475US12221450B15-(substitutedphenyl)-7-thioxo-7,8-dihydropyrimido[4,5-d]pyrimidine-2,4(1H,3H)-dione analogues as antibacterial agentsUNIV KING FAISAL·Filed 2024·Granted Feb 11, 2025·0 cites·14 claims
- 0574US11976076B1Substituted 7,8-dihydropyrimido[4,5-d]pyrimidines as anti-tubercular agentsUNIV KING FAISAL·Filed 2023·Granted May 7, 2024·0 cites·20 claims
- 0673US12187733B15-(Substitutedphenyl)-7-Imino-7,8-Dihydropyrimido[4,5-d]pyrimidine-2,4(1H,3H)-dione analogues as anti-inflammatory agentsUNIV KING FAISAL·Filed 2023·Granted Jan 7, 2025·0 cites·8 claims
- 0773US12145936B17-Imino-5-(1H-indol-3-yl)-1,3-substituted-7,8-dihdropyrimido[4,5-d]pyrimidine-2,4(1H,3H)-dione as anti-inflammatory agentsUNIV KING FAISAL·Filed 2023·Granted Nov 19, 2024·0 cites·17 claims
- 0873US11958857B15-(1H-indol-3-yl)-1,3-substitutedpyrimido[4,5-d]pyrimidine-2,4,7(1H,3H,8H)-trione as anticancer agentsUNIV KING FAISAL·Filed 2023·Granted Apr 16, 2024·0 cites·13 claims
- 0972US11932649B15-(3-substituted phenyl)-pyrimido[4,5-d]pyrimidine-2,4,7(1H,3H,8H)-trione derivatives as anticancer agentsKING FAISAL UNIVERISTY·Filed 2023·Granted Mar 19, 2024·0 cites·13 claims
Join the waitlist — get patent alerts
Get an alert when Vinuta Kamat files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →